Tumor-Mediated Hearing Loss in Neurofibromatosis Type II

Project: Research project

Project Details

Description

PROJECT NARRATIVE The relevance of this proposed project is to develop new therapies to preserve hearing in individuals with Neurofibromatosis Type II vestibular schwannomas for which there are no effective therapies. Hearing loss in Neurofibromatosis Type II affects patient safety, understanding, communication, and quality of life.
StatusActive
Effective start/end date12/1/1811/30/22

Funding

  • National Institute on Deafness and other Communication Disorders: $506,658.00
  • National Institute on Deafness and other Communication Disorders: $167,730.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.